“real addiction treatment”

I've previously expressed concern about the medicalization of addiction treatment as health care reform takes effect. Here's an ASAM member's complaint that addiction medicine physicians have not sufficiently medicalized their treatment services: I also respect those individuals who have suffered from the disease of addiction and have found help with 12-Step based programs. I understand … Continue reading “real addiction treatment”

bringing recognition, respectability and rigor

Remember that post a few weeks ago about medicalization of addiction treatment? Here it comes: Boosting interest in addiction medicine are a handful of promising new pharmaceuticals, most notably buprenorphine (sold under brand names like Suboxone), which has been proven to ease withdrawal symptoms in heroin addicts and subsequently block cravings,though it causes side effects … Continue reading bringing recognition, respectability and rigor

Naltrexone doesn’t work but Vivitrol gaining momentum

Bad news for naltrexone: Compared to placebo, or to no medication or alternative medications, prescribing oral naltrexone led to no statistically significant differences in the primary retention/abstinence outcomes. The main problem associated with oral naltrexone was high treatment drop-out – across the 13 included studies, 72% of patients did not complete treatment. Newer implant and … Continue reading Naltrexone doesn’t work but Vivitrol gaining momentum

Catching addiction?

I think this post downplays the legitimate concerns associated with the explosion in prescription opiate misuse. In a post last week, I said this about prescription opiates: ... they’re the fastest growing segment of the drug problem in the states. And, they’re currently associated with high rates of OD. And, it’s increasingly associated with crime. And, they’ve surpassed marijuana … Continue reading Catching addiction?